Geoff Cook
Noom Adds $29 Oral Weight Loss Med Dubbed a “Miracle Drug”
Digital healthcare platform Noom is launching oral weight loss medication, beginning with FDA-approved Metformin.
The Business of GLP-1s: Inside the New Weight Loss Drug Ecosystem
As GLP-1 drugs surge, here's how telehealth companies and brick-and-mortar fitness giants are responding to the Ozempic era.
Zumba, Noom Partner on Fitness Content, Instructor Coaching
Zumba instructors can gain an edge by becoming Noom Mindset Coaches as the dance-fitness brand continues to expand its reach.
Can Fitness Programs Help Ozempic Users Keep Their Muscle?
A new market has emerged which focuses on maintaining the lean muscle mass of consumers taking weight-loss drugs like Ozempic.
Noom Names Geoff Cook CEO as it Enters Weight Loss Meds Sector
Noom co-founder Saeju Jeong will continue as the wellness company's executive chairman of the board after serving as CEO for 16 years.
